Products
Our first product is a cytokine inhibitor known as GLB333. This product once used can prevent the action of those molecules and mediators that are involved in the worsening of tissue injury and causing pain. GLB333 is a biopharmaceutical drug in the mid stage of development. The product is believed to have powerful effect on preventing the action of those cytokines that are release around the damaged tissue and lead to sever inflammation and pain. It is our belief this is only breakthrough in the management of systemic tissue injury and treatment of pain.
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM